Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1995-7-10
|
pubmed:abstractText |
To determine the prevalence of the factor V Leiden gene mutation in relation to the phenotypes of cerebral infarction and cerebral hemorrhage, we studied 386 randomly selected cases of acute stroke and 247 control subjects. Factor V genotype was determined by amplification of a 267-bp sequence of exon/intron 10 of the factor V gene. Levels of prothrombin fragment F(1 + 2), a marker of thrombin generation, were determined in both acute and convalescent stroke and related to factor V genotype. Prothrombin fragment F(1 + 2) was assessed by using an enzyme-linked immunosorbent assay. Sixteen stroke cases (4.1%) were identified as having the mutation compared with 14 (5.6%) control subjects. Prothrombin fragment F(1 + 2) levels were estimated in 191 cases and found to be elevated both acutely and after 3 months, but they were not related to factor V genotype. Prothrombin fragment F(1 + 2) is elevated in acute stroke and requires further evaluation in relation to cerebrovascular disease. These results suggest that the factor V Leiden gene mutation is not a risk factor for arterial thrombosis causing stroke.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Factor V,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/Prothrombin,
http://linkedlifedata.com/resource/pubmed/chemical/Thrombin,
http://linkedlifedata.com/resource/pubmed/chemical/prothrombin fragment 1.2
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1079-5642
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
783-5
|
pubmed:dateRevised |
2009-9-29
|
pubmed:meshHeading |
pubmed-meshheading:7773734-Base Sequence,
pubmed-meshheading:7773734-Case-Control Studies,
pubmed-meshheading:7773734-Cerebrovascular Disorders,
pubmed-meshheading:7773734-Exons,
pubmed-meshheading:7773734-Factor V,
pubmed-meshheading:7773734-Genotype,
pubmed-meshheading:7773734-Humans,
pubmed-meshheading:7773734-Introns,
pubmed-meshheading:7773734-Molecular Sequence Data,
pubmed-meshheading:7773734-Mutation,
pubmed-meshheading:7773734-Peptide Fragments,
pubmed-meshheading:7773734-Prospective Studies,
pubmed-meshheading:7773734-Prothrombin,
pubmed-meshheading:7773734-Risk Factors,
pubmed-meshheading:7773734-Thrombin
|
pubmed:year |
1995
|
pubmed:articleTitle |
Factor V Leiden gene mutation and thrombin generation in relation to the development of acute stroke.
|
pubmed:affiliation |
Diabetes and Thrombosis Research Group, School of Medicine, University of Leeds, Leeds General Infirmary, UK.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|